Therapeutic Asset Ratings
261 results matching 1 filter
128,359 assets · 8,667 sponsors · 3,127 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ASPARAGINASE
adult acute lymphoblastic leukemia
Institute of Hematology & Blood Diseases Hospital, China
P4
BBB
(78)
Cyclophosphamide
Recurrent Adult Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P4
BBB
(76)
Cytosin-Arabinosid
Recurrent Adult Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P4
BBB
(76)
Fludarabine
Recurrent Adult Diffuse Large Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P4
BBB
(76)
(+)-VINCRISTINE
Recurrent Adult Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P4
BBB
(76)
Daunorubicin
adult acute lymphoblastic leukemia
Institute of Hematology & Blood Diseases Hospital, China
P4
BBB
(74)
Busulphan
disease related to hematopoietic stem cell transplant
Institute of Hematology & Blood Diseases Hospital, China
P3
BBB
(74)
Cyclophosphamide
Waldenstrom macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China
P2
BBB
(74)
Fludarabine
Waldenstrom macroglobulinemia
Institute of Hematology & Blood Diseases Hospital, China
P3
BBB
(73)
DEXAMETHASONE
Recurrent Childhood Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
BBB
(72)
Benadryl
Refractory Chronic Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P2
BBB
(72)
Fludarabine
Recurrent Adult Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P4
BB
(71)
sb-497115-gr
thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China
P4
BB
(71)
Evomela
disease related to hematopoietic stem cell transplant
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(70)
PREDNISONE TABLETS
Recurrent Childhood Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(70)
(+)-VINCRISTINE
Lymphoblastic Leukemia, Acute, Childhood
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(70)
Vinorelbine
Aggressive Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(70)
Idarubicine
acute myeloid leukemia
Institute of Hematology & Blood Diseases Hospital, China
P4
BB
(69)
ETOPOSIDE
T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(69)
Benadryl
Recurrent Grade 1 Follicular Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P2
BB
(69)
IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER
hemophilia
Institute of Hematology & Blood Diseases Hospital, China
P2
BB
(69)
Thalidomide
plasma cell myeloma
Institute of Hematology & Blood Diseases Hospital, China
P4
BB
(68)
Benadryl
Recurrent Adult Diffuse Large Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(68)
Fludarabine
indolent B-cell non-Hodgkin lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(68)
PREDNISONE TABLETS
adult acute lymphoblastic leukemia
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(68)
Showing 1 to 25 of 261 assets
Previous
Page 1 of 11
Next